STANDARD BIOTOOLS INC. (LAB)

0.91 0 (0%)

As of 2026-04-02 15:10:04 EST

Standard BioTools Inc., previously known as Fluidigm Corp., is an American life science tools company that offers analytical mass cytometry systems for flow cytometry and tissue imaging, along with associated assays and reagents, as well as an automated genomic analysis instrument and a variety of microfluidic arrays, or integrated fluidic circuits (IFCs), and consumables with fully kitted reagents. Custom assays and services are available with all systems and applications.

Traded asNasdaq: LAB
ISINUS34385P1084
CIK0001162194
LEI—
EIN770513190
Sector—
IndustryLaboratory Analytical Instruments
CEOMichael Egholm
Employees615
Fiscal Year End1231
Address50 MILK STREET, BOSTON, MA, 02109
Phone6502666000
Websitehttps://standardbio.com
Stock Quotes
trading_symbolregistrant_nametimepricechangepercentage_change
LABSTANDARD BIOTOOLS INC.2026-04-02 15:10:040.9100
This is a preview of the latest data. Subscribe to access the full data.
Company Information
trading_symbolcentral_index_keyregistrant_nameisin_numberlei_numberein_numberexchangesic_codesic_descriptionfiscal_year_endstate_of_incorporationaddress_streetaddress_cityaddress_stateaddress_zip_codeaddress_countryaddress_country_codephone_numbermailing_addressbusiness_addressformer_nameindustryfounding_datechief_executive_officernumber_of_employeeswebsitemarket_capshares_issuedshares_outstandingdescriptionupdate_time
LAB0001162194STANDARD BIOTOOLS INC.US34385P1084—770513190Nasdaq3826Laboratory Analytical Instruments1231DE50 MILK STREETBOSTONMA02109UNITED STATESUS650266600050 MILK STREET, BOSTON, MA, 0210950 MILK STREET, BOSTON, MA, 02109FLUIDIGM CORP—1999Michael Egholm615https://standardbio.com290,900,000404,961,000390,071,506Standard BioTools Inc., previously known as Fluidigm Corp., is an American life science tools company that offers analytical mass cytometry systems for flow cytometry and tissue imaging, along with associated assays and reagents, as well as an automated genomic analysis instrument and a variety of microfluidic arrays, or integrated fluidic circuits (IFCs), and consumables with fully kitted reagents. Custom assays and services are available with all systems and applications.2026-04-02 18:15:27
This is a preview of the latest data. Subscribe to access the full data.
LAB Stock Price (End-of-Day)
This is a preview of the latest data. Subscribe to access the full data.
LAB Stock Price (1-Minute)
This is a preview of the latest data. Subscribe to access the full data.
Market Cap
Fiscal YearMarket CapChange In Market CapPercentage Change In Market CapShares OutstandingChange In Shares OutstandingPercentage Change In Shares Outstanding
2025290,900,000-142,200,000-32.8331390,071,50611,085,1442.9249
2024433,100,000300,400,000226.3753378,986,362125,6760.0332
2023132,700,0006,852,3175.4449378,860,686299,796,758379.1827
This is a preview of the latest data. Subscribe to access the full data.
Executive Compensation
Executive NameExecutive PositionFiscal YearSalaryBonusStock AwardsIncentive Plan CompensationOther CompensationTotal Compensation
Colin MccrackenChief Commercial Officer2021387,8660943,584054,9031,386,353
Bradley KregerSenior Vice President2021344,7600546,58603,000894,346
Stephen ChristopherCEO, President2021595,00002,677,147039,5153,311,663
Vikram JogChief Financial Officer2021384,3000718,36403,0001,105,664
Nicholas KhadderSecretary, General Counsel, Senior Vice President2021352,6830564,87603,000920,559
This is a preview of the latest data. Subscribe to access the full data.
Employee Count
Fiscal YearEmployee Count
2025389
2024818
2023928
This is a preview of the latest data. Subscribe to access the full data.
Income Statements
Fiscal Year202520242023
Revenue85,331,000174,432,000106,340,000
Cost Of Revenue42,788,00090,170,00055,890,000
Gross Profit42,543,00084,262,00050,450,000
Research And Development Expenses25,987,00062,411,00025,948,000
General And Administrative Expenses109,861,000156,608,00087,541,000
Operating Expenses152,792,000259,498,000127,050,000
Operating Income-110,249,000-175,236,000-76,600,000
Net Income-74,896,000-138,885,000-74,656,000
Earnings Per Share Basic-0.2-0.52-0.94
Earnings Per Share Diluted-0.2-0.52-0.94
Weighted Average Shares Outstanding Basic381,623,000353,245,00079,160,000
Weighted Average Shares Outstanding Diluted381,623,000353,245,00079,160,000
This is a preview of the latest data. Subscribe to access the full data.
Balance Sheet Statements
Fiscal Year202520242023
Cash And Cash Equivalents120,863,000166,728,00051,704,000
Marketable Securities Current66,712,000126,146,00063,191,000
Accounts Receivable13,431,00033,608,00019,660,000
Inventories19,981,00040,737,00020,533,000
Non Trade Receivables———
Other Assets Current———
Total Assets Current454,264,000375,880,000158,215,000
Marketable Securities Non Current25,701,000——
Property Plant And Equipment19,275,00042,556,00024,187,000
Other Assets Non Current3,154,0006,301,0002,285,000
Total Assets Non Current46,007,00071,384,00054,850,000
Total Assets567,754,000612,344,000323,067,000
Accounts Payable5,407,00012,282,0009,236,000
Deferred Revenue38,949,00013,118,00011,607,000
Short Term Debt—05,000,000
Other Liabilities Current29,783,00030,739,0009,152,000
Total Liabilities Current108,308,00065,894,000109,327,000
Long Term Debt299,000299,00063,513,000
Other Liabilities Non Current1,215,0006,962,0001,065,000
Total Liabilities Non Current35,155,00074,728,00050,538,000
Total Liabilities143,463,000140,622,000159,865,000
Common Stock404,000396,00083,000
Retained Earnings-1,260,547,000-1,185,651,000-1,000,752,000
Accumulated Other Comprehensive Income-1,492,0001,225,000-2,221,000
Total Shareholders Equity424,291,000471,722,000-148,051,000
This is a preview of the latest data. Subscribe to access the full data.
Cash Flow Statements
Fiscal Year202520242023
Depreciation And Amortization9,262,00012,300,00012,673,000
Share Based Compensation Expense29,613,00031,732,00013,123,000
Other Non Cash Income Expense———
Change In Accounts Receivable1,361,000-8,967,0002,991,000
Change In Inventories11,524,0009,879,0004,914,000
Change In Non Trade Receivables———
Change In Other Assets———
Change In Accounts Payable2,437,000-12,975,0001,618,000
Change In Other Liabilities-208,000-4,184,0003,212,000
Cash From Operating Activities-74,343,000-143,454,000-43,287,000
Purchases Of Marketable Securities6,857,000256,119,00094,896,000
Sales Of Marketable Securities———
Acquisition Of Property Plant And Equipment8,303,0008,355,0002,831,000
Acquisition Of Business01,385,000—
Other Investing Activities———
Cash From Investing Activities27,409,000363,174,00020,237,000
Tax Withholding For Share Based Compensation484,000459,000139,000
Payments Of Dividends———
Issuance Of Common Stock———
Repurchase Of Common Stock040,490,0005,414,000
Issuance Of Long Term Debt———
Repayment Of Long Term Debt———
Other Financing Activities——827,000
Cash From Financing Activities570,000-102,616,000-6,809,000
Change In Cash-45,522,000116,319,000-29,825,000
Cash At End Of Period120,863,000166,728,00051,704,000
Income Taxes Paid-73,000607,000801,000
Interest Paid15,0003,088,0003,819,000
This is a preview of the latest data. Subscribe to access the full data.
Key Metrics
Fiscal Year202520242023
Earnings Per Share-0.2-0.52-0.94
Price To Earnings Ratio-6.4-3.3654-2.3511
Earnings Growth Rate-61.5385-44.6809-61.3169
Price Earnings To Growth Ratio0.1040.07530.0383
Book Value Per Share1.11181.33542.0617
Price To Book Ratio1.15131.31051.0719
Ebitda-65,707,000-125,978,000-56,615,000
Enterprise Value367,913,440451,749,750191,752,600
Dividend Yield———
Dividend Payout Ratio———
Debt To Equity Ratio0.00070.0006-0.4628
Capital Expenditures-14,019,00030,669,00011,208,000
Free Cash Flow-60,324,000-174,123,000-54,495,000
Return On Equity-0.1765-0.29440.5043
One Year Beta1.52321.63031.5298
Three Year Beta1.54411.57471.4819
Five Year Beta1.50521.35431.3154
This is a preview of the latest data. Subscribe to access the full data.
Insider Transactions
Insider NameRelationship To IssuerTransaction DateAmount Of SecuritiesAcquired Or DisposedSecurities Owned Following Transaction
Carey Thomas D.Director2026-02-2651,282A245,340
Cox TroyDirector2026-02-2657,264A376,586
Casdin EliDirector, 10% owner2026-02-2652,991A2,954,053
Kim Hanjoon AlexChief Financial Officer2026-02-2312,740D2,407,346
Mackay SeanSVP & Chief Business Officer2026-02-2319,661D760,174
This is a preview of the latest data. Subscribe to access the full data.
Institutional Holdings
Investor NamePeriod Of ReportMarket ValueAmount Of SecuritiesPrice Per Security
GOLDMAN SACHS GROUP INC2025-12-31673,351526,0551.28
JOHNSON & JOHNSON2025-12-31399,318311,9671.28
Rockefeller Capital Management L.P.2025-12-31568,504444,1441.28
Corient Private Wealth LLC2025-12-3116,64013,0001.28
Caitong International Asset Management Co., Ltd2025-12-312111651.2788
This is a preview of the latest data. Subscribe to access the full data.
Mutual Fund Holdings
Registrant NamePeriod Of ReportFund NameFund SymbolAmount Of UnitsValue In UsdPercentage Value Compared To Assets
Global X Funds2026-01-31Global X Russell 2000 ETFRSSL135,282189,394.80.0137
ProFunds2026-01-31SMALL-CAP PROFUND SERVICE CLASSSLPSX3154410.0059
ProFunds2026-01-31SMALL-CAP PROFUND INVESTOR CLASSSLPIX3154410.0059
ProFunds2026-01-31ULTRASMALL-CAP PROFUND SERVICE CLASSUAPSX3,8155,3410.0101
ProFunds2026-01-31ULTRASMALL-CAP PROFUND INVESTOR CLASSUAPIX3,8155,3410.0101
This is a preview of the latest data. Subscribe to access the full data.